US Transdermal Patch Market & Clinical Trial Insight
|出版日期||內容資訊||英文 300 Pages
|美國的經皮吸收貼片市場與臨床實驗分析 US Transdermal Patch Market & Clinical Trial Insight|
|出版日期: 2015年11月03日||內容資訊: 英文 300 Pages||
美國和全球其他市場比較，其經皮貼片消費者群也極度高。女性用避孕藥、尼古丁替代療法 (NRT) 等在近數年更是得到各方注目。胰島素貼片、疫苗３前雖仍處於實驗階段，但今後數年中可望產品化。
本報告提供美國的經皮吸收貼片市場相關調查分析，提供您市場概要，價值鏈分析，醫藥品受託製造廠商 (CMO) 、臨床實驗平台分析，臨床實驗平台，前臨床階段的主要產品，已上市產品等系統性資訊。
Innovations in pharmaceutical industry have a long track record of showing commercialization potential with respect to emerging and feasible technology. In US, such innovations have high level of acceptance among various stake holders of the pharmaceutical industry. Transdermal patches have emerged as one such innovations which have rich history but main development has been observed in past decade. They have been improved from a mere piece of tape dipped in formulation to complex matrix system containing therapeutics offering higher control over drug delivery. Long-term usage, high cost-effectiveness, high compliance rates and easy availability are some of the major factors behind the growth of transdermal patches in US.
Consumer base for transdermal patches is quite high in US in comparison to other markets across the globe. Segments like female contraceptives and Nicotine Replacement Therapy (NRT) have received lots of attention in past years. Indications like Parkinson's disease and Alzheimer's disease have few transdermal patches and have unexplored opportunities in US market. While Insulin and vaccine patches are at different stages of clinical trials which would be introduced in coming years. Unexplored disease segments have less competition and lack of transdermal patches makes them suitable choice for potential transdermal patch developers. This scenario suggests that US transdermal patch market has lots of commercialization opportunities that have to be reaped in coming years.
Some of the transdermal patches have completed their product life cycle and have given way to generic transdermal patches. Several small/mid-sized transdermal patch developers can take benefit of this scenario. Side-by-side, transdermal manufacturers have developed capabilities to customize products according to client's necessities. Improvement of transdermal patch technology is also expected to place as material science and associated fields are also developing. These observations suggest that US transdermal patch market will offer several commercialization opportunities. In this way, US transdermal patch segment shows progress at every level reflecting that this segment is expected to grow several folds in coming years.
“US Transdermal Patch Market & Clinical Trial Insight” Report Highlights: